{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:04:27Z","timestamp":1778857467170,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    WD40 and SOCS box protein-2 (WSB2), a member of the large family of suppressor of cytokine signaling (SOCS)-box proteins, has recently been identified as a substrate receptor of cullin 5 E3 ligase that plays an important role in proteomic regulation through substrate ubiquitination and proteasomal degradation. Here we report five patients from four unrelated families presenting with neurodevelopmental delay, dysmorphic features, brain structural abnormalities with or without growth restriction, hypotonia, and microcephaly, all of whom are homozygous for extremely rare and predicted loss-of-function (pLoF) or missense variants in\n                    <jats:italic>WSB2<\/jats:italic>\n                    , inherited from consanguineous parents. The\n                    <jats:italic>Wsb2<\/jats:italic>\n                    -mutant mice exhibited several neurological findings that included hyperactivity, altered exploration, and hyper alertness. They also weighed less, had a lower heart rate, and presented an abnormal retinal blood vessel morphology and vasculature pattern along with decreased total thickness of the retina. Our findings suggest that homozygous LoF\n                    <jats:italic>WSB2<\/jats:italic>\n                    variants cause a novel neurodevelopmental disorder in humans with similar neurologic and developmental findings seen in\n                    <jats:italic>Wsb2<\/jats:italic>\n                    -mutant mouse models.\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01863-4","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T15:32:52Z","timestamp":1747323172000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recessive variants in WSB2 encoding a substrate receptor of E3 ubiquitin ligase underlie a neurodevelopmental syndrome"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-8674","authenticated-orcid":false,"given":"Shiyu","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gailus-Durner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobbi","family":"McGivern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kottmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai-Lan","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6631-0376","authenticated-orcid":false,"given":"Hagar","family":"Mor-Shaked","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Elpeleg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erfan","family":"Aref-Eshghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda C.","family":"Brodeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Schmitz-Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casie A.","family":"Genetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Picker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem Ibrahim","family":"Bux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawfeg","family":"Ben-Omran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Harel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-2353","authenticated-orcid":false,"given":"Martin Hrab\u011b","family":"de Angelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"German Mouse Clinic Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana Veronica","family":"Amarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Spielmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Sanz-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"da Silva-Buttkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia RV","family":"Dragano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lore","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine M.","family":"H\u00f6lter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Seisenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Aguilar-Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-0456","authenticated-orcid":false,"given":"Pankaj B.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"1863_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0566-4","volume":"562","author":"MEK Niemi","year":"2018","unstructured":"Niemi MEK, Martin HC, Rice DL, Gallone G, Gordon S, Kelemen M, et al. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature. 2018;562:268\u201371.","journal-title":"Nature"},{"key":"1863_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/bies.20843","volume":"30","author":"M Ding","year":"2008","unstructured":"Ding M, Shen K. The role of the ubiquitin proteasome system in synapse remodeling and neurodegenerative diseases. Bioessays. 2008;30:1075\u201383.","journal-title":"Bioessays"},{"key":"1863_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fnmol.2017.00151","volume":"10","author":"A Upadhyay","year":"2017","unstructured":"Upadhyay A, Joshi V, Amanullah A, Mishra R, Arora N, Prasad A, et al. E3 ubiquitin ligases neurobiological mechanisms: development to degeneration. Front Mol Neurosci. 2017;10:151.","journal-title":"Front Mol Neurosci"},{"key":"1863_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrm.2017.83","volume":"19","author":"M Rape","year":"2018","unstructured":"Rape M. Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol. 2018;19:59\u201370.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1863_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","volume":"28","author":"MF Schmidt","year":"2021","unstructured":"Schmidt MF, Gan ZY, Komander D, Dewson G. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death Differ. 2021;28:570\u201390.","journal-title":"Cell Death Differ"},{"key":"1863_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.733012","volume":"14","author":"F Ebstein","year":"2021","unstructured":"Ebstein F, Kury S, Papendorf JJ, Kruger E. Neurodevelopmental disorders (NDD) caused by genomic alterations of the ubiquitin-proteasome system (UPS): the possible contribution of immune dysregulation to disease pathogenesis. Front Mol Neurosci. 2021;14:733012.","journal-title":"Front Mol Neurosci"},{"key":"1863_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41418-020-00667-x","volume":"28","author":"F Le Guerroue","year":"2021","unstructured":"Le Guerroue F, Youle RJ. Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective. Cell Death Differ. 2021;28:439\u201354.","journal-title":"Cell Death Differ"},{"key":"1863_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2015.03.002","volume":"25","author":"MJ Clague","year":"2015","unstructured":"Clague MJ, Heride C, Urbe S. The demographics of the ubiquitin system. Trends Cell Biol. 2015;25:417\u201326.","journal-title":"Trends Cell Biol"},{"key":"1863_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-biochem-090120-013613","volume":"90","author":"JW Harper","year":"2021","unstructured":"Harper JW, Schulman BA. Cullin-RING ubiquitin ligase regulatory circuits: a quarter century beyond the F-box hypothesis. Annu Rev Biochem. 2021;90:403\u201329.","journal-title":"Annu Rev Biochem"},{"key":"1863_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng0197-70","volume":"15","author":"T Kishino","year":"1997","unstructured":"Kishino T, Lalande M, Wagstaff J. UBE3A\/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70\u20133.","journal-title":"Nat Genet"},{"key":"1863_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ajhg.2021.01.008","volume":"108","author":"PL Weng","year":"2021","unstructured":"Weng PL, Majmundar AJ, Khan K, Lim TY, Shril S, Jin G, et al. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis. Am J Hum Genet. 2021;108:357\u201367.","journal-title":"Am J Hum Genet"},{"key":"1863_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajhg.2021.03.007","volume":"108","author":"SM White","year":"2021","unstructured":"White SM, Bhoj E, Nellaker C, Lachmeijer AMA, Marshall AE, Boycott KM, et al. A DNA repair disorder caused by de novo monoallelic DDB1 variants is associated with a neurodevelopmental syndrome. Am J Hum Genet. 2021;108:749\u201356.","journal-title":"Am J Hum Genet"},{"key":"1863_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1073\/pnas.95.1.114","volume":"95","author":"DJ Hilton","year":"1998","unstructured":"Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA. 1998;95:114\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1863_CR14","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1074\/jbc.M706987200","volume":"283","author":"N Mahrour","year":"2008","unstructured":"Mahrour N, Redwine WB, Florens L, Swanson SK, Martin-Brown S, Bradford WD, et al. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem. 2008;283:8005\u201313.","journal-title":"J Biol Chem"},{"key":"1863_CR15","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/sj.onc.1210004","volume":"26","author":"SJ Erkeland","year":"2007","unstructured":"Erkeland SJ, Aarts LH, Irandoust M, Roovers O, Klomp A, Valkhof M, et al. Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation and differentiation signaling. Oncogene. 2007;26:1985\u201394.","journal-title":"Oncogene"},{"key":"1863_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbrc.2010.01.004","volume":"392","author":"H Nara","year":"2010","unstructured":"Nara H, Onoda T, Rahman M, Araki A, Juliana FM, Tanaka N, et al. Regulation of interleukin-21 receptor expression and its signal transduction by WSB-2. Biochem Biophys Res Commun. 2010;392:171\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1863_CR17","doi-asserted-by":"publisher","first-page":"e80327","DOI":"10.7554\/eLife.80327","volume":"12","author":"K Lu","year":"2023","unstructured":"Lu K, Zhang M, Wei G, Xiao G, Tong L, Chen D. Multiple cullin-associated E3 ligases regulate cyclin D1 protein stability. Elife. 2023;12:e80327.","journal-title":"Elife"},{"key":"1863_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s12276-023-01142-6","volume":"56","author":"X Li","year":"2024","unstructured":"Li X, Zhang CC, Lin XT, Zhang J, Zhang YJ, Yu HQ, et al. Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Exp Mol Med. 2024;56:177\u201391.","journal-title":"Exp Mol Med"},{"key":"1863_CR19","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1093\/nar\/gkae161","volume":"52","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yu Y, Zou X, Du Y, Liang Q, Gong M, et al. WSB1\/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-kappaB termination. Nucleic Acids Res. 2024;52:4969\u201384.","journal-title":"Nucleic Acids Res"},{"key":"1863_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.biopha.2012.02.007","volume":"66","author":"P Mutlu","year":"2012","unstructured":"Mutlu P, Ural AU, Gunduz U. Differential oncogene-related gene expressions in myeloma cells resistant to prednisone and vincristine. Biomed Pharmacother. 2012;66:506\u201311.","journal-title":"Biomed Pharmacother"},{"key":"1863_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108974","volume":"116","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li Z, Zhao W, Hu H, Zhao L, Zhu Y, et al. WD repeat and SOCS box containing protein 2 in the proliferation, cycle progression, and migration of melanoma cells. Biomed Pharmacother. 2019;116:108974.","journal-title":"Biomed Pharmacother"},{"key":"1863_CR22","doi-asserted-by":"publisher","first-page":"7394","DOI":"10.21037\/tcr-20-2450","volume":"9","author":"X Wei","year":"2020","unstructured":"Wei X, Liao J, Lei Y, Li M, Zhao G, Zhou Y, et al. WSB2 as a target of Hedgehog signaling promoted the malignant biological behavior of Xuanwei lung cancer through regulating Wnt\/beta-catenin signaling. Transl Cancer Res. 2020;9:7394\u2013404.","journal-title":"Transl Cancer Res"},{"key":"1863_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01916-z","volume":"16","author":"E Wohler","year":"2021","unstructured":"Wohler E, Martin R, Griffith S, Rodrigues EDS, Antonescu C, Posey JE, et al. PhenoDB, GeneMatcher and VariantMatcher, tools for analysis and sharing of sequence data. Orphanet J Rare Dis. 2021;16:365.","journal-title":"Orphanet J Rare Dis"},{"key":"1863_CR24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/humu.22844","volume":"36","author":"N Sobreira","year":"2015","unstructured":"Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928\u201330.","journal-title":"Hum Mutat"},{"key":"1863_CR25","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/humu.23655","volume":"39","author":"H Arachchi","year":"2018","unstructured":"Arachchi H, Wojcik MH, Weisburd B, Jacobsen JOB, Valkanas E, Baxter S, et al. matchbox: an open-source tool for patient matching via the Matchmaker Exchange. Hum Mutat. 2018;39:1827\u201334.","journal-title":"Hum Mutat"},{"key":"1863_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/gim.2015.148","volume":"18","author":"K Retterer","year":"2016","unstructured":"Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18:696\u2013704.","journal-title":"Genet Med"},{"key":"1863_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"1863_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbr.2017.09.048","volume":"352","author":"H Fuchs","year":"2018","unstructured":"Fuchs H, Aguilar-Pimentel JA, Amarie OV, Becker L, Calzada-Wack J, Cho YL, et al. Understanding gene functions and disease mechanisms: Phenotyping pipelines in the German Mouse Clinic. Behav Brain Res. 2018;352:187\u201396.","journal-title":"Behav Brain Res"},{"key":"1863_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ymeth.2010.08.006","volume":"53","author":"H Fuchs","year":"2011","unstructured":"Fuchs H, Gailus-Durner V, Adler T, Aguilar-Pimentel JA, Becker L, Calzada-Wack J, et al. Mouse phenotyping. Methods. 2011;53:120\u201335.","journal-title":"Methods"},{"key":"1863_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nmeth0605-403","volume":"2","author":"V Gailus-Durner","year":"2005","unstructured":"Gailus-Durner V, Fuchs H, Becker L, Bolle I, Brielmeier M, Calzada-Wack J, et al. Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nat Methods. 2005;2:403\u20134.","journal-title":"Nat Methods"},{"key":"1863_CR31","doi-asserted-by":"publisher","first-page":"e1002151","DOI":"10.1371\/journal.pbio.1002151","volume":"13","author":"NA Karp","year":"2015","unstructured":"Karp NA, Meehan TF, Morgan H, Mason JC, Blake A, Kurbatova N, et al. Applying the ARRIVE guidelines to an in vivo database. PLoS Biol. 2015;13:e1002151.","journal-title":"PLoS Biol"},{"key":"1863_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00335-023-09986-z","volume":"34","author":"P da Silva-Buttkus","year":"2023","unstructured":"da Silva-Buttkus P, Spielmann N, Klein-Rodewald T, Schutt C, Aguilar-Pimentel A, Amarie OV, et al. Knockout mouse models as a resource for the study of rare diseases. Mamm Genome. 2023;34:244\u201361.","journal-title":"Mamm Genome"},{"key":"1863_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2020.04.003","volume":"67","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Xiong X, Sun Y. Cullin-RING ligase 5: functional characterization and its role in human cancers. Semin Cancer Biol. 2020;67:61\u201379.","journal-title":"Semin Cancer Biol"},{"key":"1863_CR34","unstructured":"Blackburn PR, Ebstein F, Hsieh TC, Motta M, Radio FC, Herkert JC, et al. Loss-of-function variants in CUL3 cause a syndromic neurodevelopmental disorder. medRxiv. 2023. https:\/\/www.medrxiv.org\/content\/10.1101\/2023.06.13.23290941v1."},{"key":"1863_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.neuron.2019.10.035","volume":"105","author":"Z Dong","year":"2020","unstructured":"Dong Z, Chen W, Chen C, Wang H, Cui W, Tan Z, et al. CUL3 deficiency causes social deficits and anxiety-like behaviors by impairing excitation-inhibition balance through the promotion of cap-dependent translation. Neuron. 2020;105:475\u201390.e6.","journal-title":"Neuron"},{"key":"1863_CR36","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/humu.23646","volume":"39","author":"I Thiffault","year":"2018","unstructured":"Thiffault I, Cadieux-Dion M, Farrow E, Caylor R, Miller N, Soden S, et al. On the verge of diagnosis: Detection, reporting, and investigation of de novo variants in novel genes identified by clinical sequencing. Hum Mutat. 2018;39:1505\u201316.","journal-title":"Hum Mutat"},{"key":"1863_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108933","volume":"27","author":"T Shim","year":"2024","unstructured":"Shim T, Kim JY, Kim W, Lee YI, Cho B, Moon C. Cullin-RING E3 ubiquitin ligase 4 regulates neurite morphogenesis during neurodevelopment. iScience. 2024;27:108933.","journal-title":"iScience"},{"key":"1863_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1086\/511134","volume":"80","author":"PS Tarpey","year":"2007","unstructured":"Tarpey PS, Raymond FL, O\u2019Meara S, Edkins S, Teague J, Butler A, et al. Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet. 2007;80:345\u201352.","journal-title":"Am J Hum Genet"},{"key":"1863_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/43213","volume":"387","author":"TA Endo","year":"1997","unstructured":"Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 1997;387:921\u20134.","journal-title":"Nature"},{"key":"1863_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/371297a0","volume":"371","author":"EJ Neer","year":"1994","unstructured":"Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature. 1994;371:297\u2013300.","journal-title":"Nature"},{"key":"1863_CR41","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1101\/gad.1256504","volume":"18","author":"CJ Sherr","year":"2004","unstructured":"Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004;18:2699\u2013711.","journal-title":"Genes Dev"},{"key":"1863_CR42","doi-asserted-by":"publisher","first-page":"11632","DOI":"10.1073\/pnas.1106230108","volume":"108","author":"AI Lukaszewicz","year":"2011","unstructured":"Lukaszewicz AI, Anderson DJ. Cyclin D1 promotes neurogenesis in the developing spinal cord in a cell cycle-independent manner. Proc Natl Acad Sci USA. 2011;108:11632\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1863_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.stem.2009.05.026","volume":"5","author":"C Lange","year":"2009","unstructured":"Lange C, Huttner WB, Calegari F. Cdk4\/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors. Cell Stem Cell. 2009;5:320\u201331.","journal-title":"Cell Stem Cell"},{"key":"1863_CR44","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105712","volume":"40","author":"S Miyashita","year":"2021","unstructured":"Miyashita S, Owa T, Seto Y, Yamashita M, Aida S, Sone M, et al. Cyclin D1 controls development of cerebellar granule cell progenitors through phosphorylation and stabilization of ATOH1. EMBO J. 2021;40:e105712.","journal-title":"EMBO J"},{"key":"1863_CR45","doi-asserted-by":"publisher","first-page":"dev158360","DOI":"10.1242\/dev.158360","volume":"145","author":"AK Jain","year":"2018","unstructured":"Jain AK, Barton MC. p53: emerging roles in stem cells, development and beyond. Development. 2018;145:dev158360.","journal-title":"Development"},{"key":"1863_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9:749\u201358.","journal-title":"Nat Rev Cancer"},{"key":"1863_CR47","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ijnp\/pyad030","volume":"26","author":"H Li","year":"2023","unstructured":"Li H, Zhang Z, Li H, Pan X, Wang Y. New insights into the roles of p53 in central nervous system diseases. Int J Neuropsychopharmacol. 2023;26:465\u201373.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1863_CR48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.14336\/AD.2016.1120","volume":"8","author":"A Szybinska","year":"2017","unstructured":"Szybinska A, Lesniak W. P53 dysfunction in neurodegenerative diseases - the cause or effect of pathological changes? Aging Dis. 2017;8:506\u201318.","journal-title":"Aging Dis"},{"key":"1863_CR49","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1172\/JCI92171","volume":"127","author":"D Lessel","year":"2017","unstructured":"Lessel D, Wu D, Trujillo C, Ramezani T, Lessel I, Alwasiyah MK, et al. Dysfunction of the MDM2\/p53 axis is linked to premature aging. J Clin Invest. 2017;127:3598\u2013608.","journal-title":"J Clin Invest"},{"key":"1863_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature13585","volume":"514","author":"JL Van Nostrand","year":"2014","unstructured":"Van Nostrand JL, Brady CA, Jung H, Fuentes DR, Kozak MM, Johnson TM, et al. Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature. 2014;514:228\u201332.","journal-title":"Nature"},{"key":"1863_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jmcb\/mjy087","volume":"11","author":"ME Bowen","year":"2019","unstructured":"Bowen ME, Attardi LD. The role of p53 in developmental syndromes. J Mol Cell Biol. 2019;11:200\u201311.","journal-title":"J Mol Cell Biol"},{"key":"1863_CR52","doi-asserted-by":"publisher","first-page":"9307","DOI":"10.3390\/ijms22179307","volume":"22","author":"YY Tsai","year":"2021","unstructured":"Tsai YY, Su CH, Tarn WY. p53 activation in genetic disorders: different routes to the same destination. Int J Mol Sci. 2021;22:9307.","journal-title":"Int J Mol Sci"},{"key":"1863_CR53","first-page":"3921","volume":"142","author":"SE Williams","year":"2015","unstructured":"Williams SE, Garcia I, Crowther AJ, Li S, Stewart A, Liu H, et al. Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in mice. Development. 2015;142:3921\u201332.","journal-title":"Development"},{"key":"1863_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8676","volume":"6","author":"M Marjanovic","year":"2015","unstructured":"Marjanovic M, Sanchez-Huertas C, Terre B, Gomez R, Scheel JF, Pacheco S, et al. CEP63 deficiency promotes p53-dependent microcephaly and reveals a role for the centrosome in meiotic recombination. Nat Commun. 2015;6:7676.","journal-title":"Nat Commun"},{"key":"1863_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nm1725","volume":"14","author":"NC Jones","year":"2008","unstructured":"Jones NC, Lynn ML, Gaudenz K, Sakai D, Aoto K, Rey JP, et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med. 2008;14:125\u201333.","journal-title":"Nat Med"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01863-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:03:11Z","timestamp":1768813391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01863-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01863-4","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BM and EAE are employees of and may own stock in GeneDx, LLC.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board (IRB) at Boston Children\u2019s Hospital (under the protocol#10-02-0253) and University of Miami (IRB protocol# 20230140). All patients or their guardians provided written informed consent under BCH protocol 10-02-0253, collaborator protocol (HMO-0306-10), or through GeneDx protocol Research to Expand the Understanding of Genetic Variants: Clinical and Genetic Correlations, Western Institutional Review Board (protocol# 20171030). Mice were housed in individually ventilated cages (IVC) available\n                      ad libitum\n                      according to the European Union directive 2010\/63\/EU, German laws, and German Mouse Clinic (GMC) housing conditions (\n                      \n                      ). All animal care and use in this study met approval by, and complied with, the rules of the district government of Upper Bavaria (Regierung von Oberbayern) Germany and were conducted according to the rules outlined by the Helmholtz Zentrum M\u00fcnchen ethical committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}